Alkem Laboratories Share Price

₹ 5,185.00

+₹40.00 (0.78%)
1D
Last updated 20 Nov, 2026, 15:28 IST
NSE: ALKEM
|
Pharmaceuticals

Alkem Laboratories Share Price Today

As of 22 Nov 2026, Alkem Laboratories share price is ₹5,185.00. The stock opened at ₹5,154.50, compared to its previous close of ₹5,145.00. During today's trading session, Alkem Laboratories share price moved in the range of ₹5,114.00 to ₹5,185.00, with an average price of ₹5,149.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,811.00 and a high of ₹5,933.50. On the performance front, Alkem Laboratories share price has declined by 4.63% over the last six months and is down 9.04% on a year-on-year basis.

Share price over the last 1 day rose from 5128.50 to 5185.00, ranging between 5124.00 and 5185.00.

₹5,114.00
0.78% up today
₹5,185.00
1D LOW
1D HIGH

Alkem Laboratories Stock Insights

Latest Earning
Op Profit TrendUp by 29.49% QoQ
Latest Earning
Net Profit TrendUp by 28.04% QoQ
Latest Earning
Revenue TrendUp by 20.38% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 7.21 % in last 1 yr
Shareholding Pattern
DIIDII decreased stake by 15.03%
Shareholding Pattern
FIIFII decreased stake by 0.89%
Alkem Laboratories stock performance
Open₹5,154.50
High₹5,185.00
Low₹5,114.00
Prev. close₹5,145.00
Alkem Laboratories trading activity
Volume69,594
Average traded price₹5,155.25
Last traded time03:28:03 20 Nov
Last traded quantity7

Circuit
L
H
₹4,666.50
₹5,703.50
52-week
L
H
₹4,811.00
₹5,933.50
Mkt Cap Cr
61,798.96

P/E
29.54

P/B
4.16

ROA
9.08%
ROE
13.91%

ROCE
17.87%

Quick Ratio
1.86

EV/EBITDA
17.62

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Alkem Lab has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Alkem Lab appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Alkem Lab revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,52,298.6441.175.079.61%13.79%18.65%2.3123.87
Divis Laboratories2,97,324.8188.4116.5215.31%18.69%23.83%3.559.25
Torrent Pharmaceuticals1,78,727.2585.159.734.7%11.42%11.37%0.7534.12
Laurus Labs1,24,001.6593.0720.4611.58%22.11%20.91%0.6852.29
Zydus Lifesciences1,19,206.7027.714.297.63%15.1%14.86%0.9116.06
Dr. Reddy's Laboratories1,16,144.5142.092.994.79%7.21%8.58%1.3519.73
Cipla1,14,312.1240.063.236.6%8.18%10.8%2.521.64
Mankind Pharma1,09,869.9948.546.257.82%12.76%14.68%0.7426.67
Aurobindo Pharma1,03,297.5925.912.626.46%10.13%12.76%1.1512.53
Lupin91,915.8917.63.8213.08%21.65%24.54%1.4210.32

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Alkem Laboratories Company Background

ISIN
INE540L01014
Sector Market Cap
₹ 61,798.96 Cr

Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.

Alkem Laboratories Financial Highlights

  • Revenue: Alkem Laboratories reported revenue of ₹15,295.62 crore in FY26 vs ₹13,458.26 crore in FY25. It showed an increase of 13.65% on a yearly basis.
  • Operating Profit: Alkem Laboratories reported an operating profit of ₹2,870.89 crore in FY26 vs ₹2,527.03 crore in FY25. It showed an increase of 13.61% on a year-on-year basis.
  • Net Profit: Alkem Laboratories reported a net profit of ₹2,353.13 crore in FY26 vs ₹2,216.00 crore in FY25. It showed an increase of 6.19% on a yearly basis.

Alkem Laboratories Quarterly Result Highlights

  • Alkem Laboratories reported revenue of ₹4,686.20 crore in Sep 2026, compared with ₹3,892.90 crore in Jun 2026, representing an increase of 20.38% on a quarter-on-quarter (QoQ) basis.
  • Alkem Laboratories reported an operating profit of ₹999.65 crore in Sep 2026, compared with ₹771.99 crore in Jun 2026, representing an increase of 29.49% on a quarter-on-quarter (QoQ) basis.
  • Alkem Laboratories reported a profit of ₹667.74 crore in Sep 2026, compared with ₹521.49 crore in Jun 2026, reflecting an increase of 28.04% on a QoQ basis.
  • The earnings per share (EPS) of Alkem Laboratories stood at ₹192.51 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
49.70%
FII
10.32%
Other DII
5.04%
Retail and other
17.15%
Mutual funds
17.79%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20259.97%
Mar 202610.16%
Jun 202610.42%
Sep 202610.32%

Alkem Laboratories Investment Returns

1 day
+0.78%

1 week
+1.39%

1 month
+3.62%

1 year
-9.04%

3 years
+18.09%

5 years
+48.92%

Alkem Laboratories Share Price History

Alkem Laboratories share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
20 Nov 26
₹5,154.50 / ₹5,185.00
+0.78%
19 Nov 26
₹5,220.00 / ₹5,145.00
-1.48%
18 Nov 26
₹5,195.00 / ₹5,222.50
+0.92%
17 Nov 26
₹5,144.50 / ₹5,175.00
+0.76%
Show more

Alkem Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹14,712.27₹12,964.52₹12,667.58₹11,599.26
Other Income₹583.35₹493.74₹310.84₹216.08
Total Revenue₹15,295.62₹13,458.26₹12,978.42₹11,815.34
Total Expenses₹12,249.90₹10,931.23₹10,833.80₹10,407.59
Profit Before Tax₹2,870.89₹2,527.03₹2,023.13₹1,304.77
Tax₹517.76₹311.03₹211.67₹297.96
Profit After Tax₹2,353.13₹2,216.00₹1,811.46₹1,006.81
EPS - Basic₹192.51₹181.11₹150.19₹82.31
EPS - Diluted₹192.51₹181.11₹150.19₹82.31

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2,870.89₹2,527.03₹2,023.13₹1,304.77
Income before WC changes₹3,007.22₹2,630.83₹2,406.70₹1,629.12
Change in Assets-₹663.72-₹454.79-₹430.50₹261.69
Change in Liabilities₹248.55₹240.82₹378.81₹65.08
Change in WC-₹415.17-₹213.97-₹51.69₹326.77
Cash flow from Operations₹1,963.03₹1,912.84₹1,948.07₹1,682.50
Cash flow from Investing-₹1,667.21-₹1,298.76-₹1,008.50₹112.84
Cash flow from Financing-₹503.40-₹810.99-₹1,145.01-₹1,760.82
Total Cash Flow-₹207.58-₹196.91-₹205.44₹34.52
Cash (Start of the year)-₹120.09₹66.31₹273.80₹232.18
Cash (End of the year)-₹342.13-₹120.09₹66.31₹273.80

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹8,662.45₹6,879.91₹5,163.32₹5,026.95
Current Assets₹12,210.52₹10,811.19₹10,411.58₹8,729.70
Total Assets₹20,872.97₹17,691.10₹15,574.90₹13,756.65
Current Liabilities₹4,782.70₹3,960.67₹3,994.55₹3,707.15
Net Current Asset₹7,427.82₹6,850.52₹6,417.03₹5,022.55
Non-Current Liabilities₹1,741.34₹1,296.80₹865.95₹614.50
Equity Capital₹14,348.93₹12,433.63₹10,714.40₹9,435.00
Total Equity & Liabilities₹20,872.97₹17,691.10₹15,574.90₹13,756.65

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹9,663.91₹8,813.44₹7,963.85₹9,054.55
Other Income₹555.17₹507.06₹305.99₹266.29
Total Revenue₹10,219.08₹9,320.50₹8,269.84₹9,320.84
Total Expenses₹7,553.37₹7,016.96₹6,611.88₹7,993.85
Profit Before Tax₹2,522.62₹2,303.54₹1,594.13₹1,326.99
Tax₹337.50₹213.82₹33.62₹192.52
Profit After Tax₹2,185.12₹2,089.72₹1,560.51₹1,134.47
EPS - Basic₹190.87₹190.77₹146.13₹94.88
EPS - Diluted₹190.87₹190.77₹146.13₹94.88

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2,671.67₹2,597.39₹1,881.03₹1,326.99
Income before WC changes₹2,606.70₹2,546.05₹2,092.77₹1,455.88
Change in Assets-₹250.29-₹179.20-₹238.27₹169.14
Change in Liabilities₹94.19₹219.19₹184.89₹36.56
Change in WC-₹156.10₹39.99-₹53.38₹205.70
Cash flow from Operations₹1,969.12₹2,189.41₹1,686.56₹1,437.42
Cash flow from Investing-₹1,461.25-₹1,007.41-₹865.60₹197.04
Cash flow from Financing-₹672.82-₹1,036.89-₹959.04-₹1,711.27
Total Cash Flow-₹164.95₹145.11-₹138.08-₹76.81
Cash (Start of the year)₹12.04-₹133.07₹5.01₹81.82
Cash (End of the year)-₹152.91₹12.04-₹133.07₹5.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹9,431.01₹8,241.60₹5,997.72₹5,959.01
Current Assets₹7,830.12₹7,354.00₹8,040.08₹6,772.21
Total Assets₹17,261.13₹15,595.60₹14,037.80₹12,731.22
Current Liabilities₹2,746.81₹2,543.44₹3,106.40₹3,044.83
Net Current Asset₹5,083.31₹4,810.56₹4,933.68₹3,727.38
Non-Current Liabilities₹515.56₹730.33₹376.79₹336.54
Equity Capital₹13,998.76₹12,321.83₹10,554.61₹9,349.85
Total Equity & Liabilities₹17,261.13₹15,595.60₹14,037.80₹12,731.22
* All values are in INR Crore
Alkem Laboratories market depth
Bid quantityBid priceAsk priceAsk quantity
005185270
0000
0000
0000
0000
Total bid quantity0
Total ask quantity270
Alkem Laboratories technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
48.98
Neutral

ATR (14)
130.93
Neutral

STOCH(9,6)
23.48
Neutral

STOCH RSI (14)
20.15
Bullish

ADX(9)
20.74
Bearish

UO(9)
48.94
Neutral

ROC(12)
-0.6
Bearish

WillR(14)
-76.52
Neutral
Period
Simple value
Exponential vaue

5D
5172.7
5187.26

10D
5243
5201.92

20D
5194.75
5200.24

50D
5202.03
5227.02

100D
5357.09
5290.2
Volume trend — traded volume by day
20 Nov0L
19 Nov2L
18 Nov0L
17 Nov1L
16 Nov0L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Alkem Laboratories
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Alkem Laboratories

Fund name
AUM
HDFC Pharma and Healthcare Fund
6.21%

Tata Nifty MidSmall Healthcare Index Fund
6.16%

Motilal Oswal Nifty MidSmall Healthcare Index Fund
6.06%

Alkem Laboratories Returns Calculator

Ex-date: 07 Aug 2026

Ex-date: 20 Feb 2026

Alkem Laboratories Latest News

2 days ago
Alkem Labs shares fall 2% as US FDA issues warning letter to its Daman manufacturing facility
4 days ago
Groww shares worth ₹1,905 crore changes hands in block deal; Alkem Labs sees trade worth ₹300 crore
1 week ago
Alkem Laboratories Q2 profit falls 12% YoY to ₹675 crore, EBITDA grows 22%; board appoints new CFO
1 month ago
Apollo Hospitals, Max Health, Fortis: Healthcare stocks to post strong Q2 earnings; volumes, capacity additions in focus
3 months ago
Alkem Laboratories Q1 results: Net profit drops 21% YoY; board approves setting up new block at Baddi plant
3 months ago
Q1 Results: Ashok Leyland, NMDC, Alkem Labs, Bharat Dynamics, Voltas, Physicswallah, others to post earnings on August 14
5 months ago
Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supply
5 months ago
Stocks to watch, June 3: NHPC, IT stocks, Alkem Labs, IndiGo, Canara Bank, Mankind Pharma
5 months ago
Stocks to watch, June 2: Anant Raj, NHPC, Ola Electric, fertiliser stocks, Wipro, NMDC, Coal India
5 months ago
Q4 results: Ashok Leyland, Bharat Dynamics, Alkem Labs, ITI, Tenneco Clean Air, Prime Focus, others to post earnings on May 28
Showing news item 1 of 10

Alkem Laboratories Share Price FAQs












Please be aware that Alkem Laboratories stock prices are subject to continuous fluctuations due to various factors.